Hanmi Holdings wins US patent on immunoglobin

Published: 2011-05-19 06:57:00

Updated: 2011-05-19 06:57:00

Hanmi Holdings said Monday it has obtained the U.S. patent entitled “A method for the mass production of immunoglobulin Fc region deleted initial methionine residues” using LAPSCOVERY Technology (Long Acting Protein/Peptide Discovery Technology).

LAPSCOVERY technology using Hanmi’s novel recom...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK